Federal Court Orders Custompax to Cease Manufacturing

The California-based dietary supplement maker was cited for multiple violations of the current good manufacturing practice and regulations.

FDA / Image: Alison Young
FDA / Image: Alison Young

According to a recent FDA News Release, a dietary supplement manufacturer is under scrutiny for violating the FDA’s manufacturing regulations. Custompax, a supplement manufacturer in Freemont, CA, sells customized dietary supplements directly to websites. Physicians can then customize their own products by configuring the type and quantity of ingredients to be packed with custom labels with unique names. This is in direct violation of the current good manufacturing practices for the following reasons:

  • Failure to adequately establish identity specifications for each component used in the manufacture of finished dietary supplements
  • Failure to establish component specifications to ensure the finished product meets specifications for purity, strength, and composition
  • Failure to establish product specifications for the identity, purity, strength, composition of the finished batch of dietary supplement
  • Failure to conduct appropriate tests or examinations to determine compliance with specifications for identity, purity, strength, and composition

The company is no longer manufacturing dietary supplements, but should they decide to in the future, they must hire an expert to ensure they’re operating properly and obtain FDA approval to resume operations.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026